J&J DePuy to sell Anika Therapeutics MONOVISC hylaronic acid injections in the US

 
 
Anika Therapeutics Announces U.S. MONOVISC® License and Supply Agreement with DePuy Mitek, Inc. (press release)
Anika Therapeutics, Inc. (NASDAQ:ANIK) today announced the signing of an exclusive, multi-year U.S. licensing and supply agreement with DePuy Mitek, Inc., a leading orthopedic sports medicine company, for Anika’s MONOVISC®, a highly purified, high molecular weight form of hyaluronic acid for treating pain in patients suffering from osteoarthritis of the knee.
In connection with the entering into of the agreement, Anika will receive an initial payment of $2.5 million. A...